Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2021

Financial Instruments [Abstract]

Schedule of classification and linkage terms of financial instruments

	NIS			USD			Other (*)			Total
December 31, 2021
Cash		72,190			753,320			28,116			853,626
Bank deposits		80,457			421,512			-			501,969
Restricted deposits		569			80			-			649
Trade receivables (net)		36			130			3,256			3,422
Other receivables		4,240			2,806			856			5,902
		157,492			1,175,848			32,228			1,365,568
Financial liabilities at amortized cost		(10,392	)		(3,623	)		(7,096	)		(21,111	)
Total net financial assets (liabilities)		147,100			1,172,225			25,132			1,344,457
December 31, 2020
Cash		1,057			584,205			76			585,338
Bank deposits		-			85,596			-			85,596
Restricted deposits		406			62			-			468
Trade receivables		17			534			162			713
Other receivables		410			19			-			429
		1,890			670,416			238			672,544
Financial liabilities at amortized cost		4,366			16,134			45			20,545
Total net financial assets (liabilities)		(2,476	)		654,282			193			651,999

(*) Mainly Euro

Schedule of sensitivity analysis of changes in exchange rate of dollar

	Profit (loss) from the change
	Thousands USD
Increase at a rate of 5%		7,355
Increase at a rate of 10%		14,710
Decrease at a rate of 5%		(7,355	)
Decrease at a rate of 10%		(14,710	)

Schedule of fair value of financial instruments position

	2020		2021
	Thousands USD		Thousands USD
Financial liabilities:
Liability in respect of warrants		11,986		3,697
Share price protection for previews shareholders of subsidiary acquired		-		5,768
Contingent consideration in business combination		-		8,792
Total		11,986		18,257
Presented under current liabilities		-		14,910
Presented under non-current liabilities		11,986		3,347

Schedule of Level 3 financial instruments carried at fair value

	2021
	Contingent consideration in business combinations
Balance as of January 1, 2021		-
Arising from business combinations (*)		(10,159	)
Changes in fair value (unrealized)		1,367
Balance as of December 31, 2021		(8,792	)

(*) See Note 9.B regarding acquisition of NanoFabrica for information in relation to the contingent consideration liability at the amount of $1,367 thousand arising from business combination and Note 20.F regarding offsetting the liability against deposit. See Note 9 (3) B  regarding acquisition of Essemtec for information in relation to the contingent consideration liability at the amount of $8,792 thousand arising from business combination.

Schedule of repayment dates of financial liabilities

	First year		More than a year		Total
	Thousands USD		Thousands USD		Thousands USD
December 31, 2021
Trade payables		2,833		-		2,833
Other payables		11,322		-		11,322
Financial derivatives		14,910		3,347		18,257
Lease liabilities		2,086		3,336		5,422
Other long-term liability		417		1,104		1,521
Liability in respect of government grants		428		1,560		1,988
		31,996		9,347		41,343
December 31, 2020
Trade payables		776		-		776
Other payables		5,910		-		5,910
Lease liabilities		-		2,618		2,618
Liability in respect of government grants		-		850		850
		6,686		3,468		10,154